Literature DB >> 33109441

Prolactin: A hormone with diverse functions from mammary gland development to cancer metastasis.

Ödül Karayazi Atıcı1, Nayantara Govindrajan2, Isbel Lopetegui-González3, Carrie S Shemanko4.   

Abstract

Prolactin has a rich mechanistic set of actions and signaling in order to elicit developmental effects in mammals. Historically, prolactin has been appreciated as an endocrine peptide hormone that is responsible for final, functional mammary gland development and lactation. Multiple signaling pathways impacted upon by the microenvironment contribute to cell function and differentiation. Endocrine, autocrine and paracrine signaling are now apparent in not only mammary development, but also in cancer, and involve multiple cell types including those of the immune system. Multiple ligands agonists are capable of binding to the prolactin receptor, potentially expanding receptor function. Prolactin has an important role not only in tumorigenesis of the breast, but also in a number of hormonally responsive cancers such as prostate, ovarian and endometrial cancer, as well as pancreatic and lung cancer. Although pituitary and extra-pituitary sources of prolactin such as the epithelium are important, stromal sourced prolactin is now also being recognized as an important factor in tumor progression, all of which potentially signal to multiple cell types in the tumor microenvironment. While prolactin has important roles in milk production including calcium and bone homeostasis, in the disease state it can also affect bone homeostasis. Prolactin also impacts metastatic cancer of the breast to modulate the bone microenvironment and promote bone damage. Prolactin has a fascinating contribution in both physiologic and pathologic settings of mammals.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone metastasis; Breast cancer; Mammary gland; Metastasis; Prolactin; Prolactin receptor

Mesh:

Substances:

Year:  2020        PMID: 33109441     DOI: 10.1016/j.semcdb.2020.10.005

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  7 in total

Review 1.  Prolactin: The Third Hormone in Breast Cancer.

Authors:  Linda A Schuler; Kathleen A O'Leary
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

Review 2.  Extracellular Vesicles in Tumors: A Potential Mediator of Bone Metastasis.

Authors:  Shenglong Li; Wei Wang
Journal:  Front Cell Dev Biol       Date:  2021-04-01

3.  Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors.

Authors:  Renato Cozzi; Maria Rosaria Ambrosio; Roberto Attanasio; Claudia Battista; Alessandro Bozzao; Marco Caputo; Enrica Ciccarelli; Laura De Marinis; Ernesto De Menis; Marco Faustini Fustini; Franco Grimaldi; Andrea Lania; Giovanni Lasio; Francesco Logoluso; Marco Losa; Pietro Maffei; Davide Milani; Maurizio Poggi; Michele Zini; Laurence Katznelson; Anton Luger; Catalina Poiana
Journal:  Eur J Endocrinol       Date:  2022-02-03       Impact factor: 6.664

Review 4.  The Relevant Participation of Prolactin in the Genesis and Progression of Gynecological Cancers.

Authors:  Adrián Ramírez-de-Arellano; Julio César Villegas-Pineda; Christian David Hernández-Silva; Ana Laura Pereira-Suárez
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-21       Impact factor: 5.555

Review 5.  Molecular Pathways in Prolactinomas: Translational and Therapeutic Implications.

Authors:  Betina Biagetti; Rafael Simò
Journal:  Int J Mol Sci       Date:  2021-10-18       Impact factor: 5.923

6.  Dynamic alteration in miRNA and mRNA expression profiles at different stages of chronic arsenic exposure-induced carcinogenesis in a human cell culture model of skin cancer.

Authors:  Mayukh Banerjee; Ana Ferragut Cardoso; Laila Al-Eryani; Jianmin Pan; Theodore S Kalbfleisch; Sudhir Srivastava; Shesh N Rai; J Christopher States
Journal:  Arch Toxicol       Date:  2021-05-25       Impact factor: 5.153

7.  The Expression of Prolactin Receptors in Benign Breast Tumors Is Not Associated with Serum Prolactin Level.

Authors:  Olena Kolomiiets; Oleksandr Yazykov; Artem Piddubnyi; Mykola Lyndin; Ivan Lukavenko; Volodymyr Andryushchenko; Anatolii Romaniuk; Roman Moskalenko
Journal:  J Clin Med       Date:  2021-12-14       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.